Provided by Tiger Trade Technology Pte. Ltd.

Global X HealthTech ETF

29.93
-0.0100-0.03%
Post-market: 30.070.1450+0.48%17:25 EDT
Volume:5K
Turnover:160.19K
Market Cap:31.42M
PE:- -
High:30.15
Open:29.82
Low:29.79
Close:29.94
52wk High:33.59
52wk Low:23.00
Shares:1.05M
Float Shares:1.05M
Volume Ratio:0.20
T/O Rate:0.51%
Dividend:0.07
Dividend Rate:0.24%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Dexcom Raises Annual Revenue Forecast on Strong Demand for Glucose Monitors

Reuters
·
Jul 31

Gartner Inc. Stock Underperforms Thursday When Compared to Competitors

Dow Jones
·
Jul 31

Tempus AI Inc Shares Fall 2% After the Bell Following Results, Outlook

THOMSON REUTERS
·
Jul 31

GUIDANCE: (TEM) Tempus AI Expects Full Year 2026 Revenue Range $1.595B - $1.605B, vs. FactSet Est of $1.59B

MT Newswires Live
·
Jul 31

Dexcom Reports Higher Profit, Raises FY Sales Outlook

Dow Jones
·
Jul 31

Tempus AI Q2 FY26 Swings to GAAP Profit of $5.64 Million; Revenue Rises 22% to $382.5 Million

Reuters
·
Jul 31

Tempus AI Q2 Revenue Slightly Beats Estimates

Reuters
·
Jul 31

Dexcom Q2 FY26 GAAP Net Income Rises 39% to $249.1 Million; Revenue Climbs 13% to $1.31 Billion

Reuters
·
Jul 31

Dexcom Q2 Revenue Beats Estimates Raises Outlook; Raises FY Revenue and Margin Guidance

Reuters
·
Jul 31

Dexcom Inc Shares Rise 4.7% After the Bell Following Results

THOMSON REUTERS
·
Jul 31

Dexcom Shares Rise 4.6% in Extended Trading After Posting Quarterly Results

THOMSON REUTERS
·
Jul 31

Dexcom Q2 Adjusted EPS USD 0.7 Vs. IBES Estimate USD 0.61

Reuters
·
Jul 31

Dexcom Outlook FY Revenue USD 5,180-5,250 Million

THOMSON REUTERS
·
Jul 31

Dexcom Q2 Adjusted Gross Profit USD 838.5 Million

THOMSON REUTERS
·
Jul 31

Tempus AI Q2 Adj. EPS $(0.04) Beats $(0.14) Estimate, Sales $382.486M Beat $379.743M Estimate

Benzinga Earnings
·
Jul 31

Tempus AI Inc Q2 Income from Operations USD -75.913 Million

THOMSON REUTERS
·
Jul 31

Tempus AI Inc Q2 Adjusted EPS USD -0.04 VS. Ibes Estimate USD -0.14

THOMSON REUTERS
·
Jul 31

tempus AI Inc Class A options imply 6.9% move in share price post-earnings

TIPRANKS
·
Jul 31

Median Technologies Partners with Canon’s Olea Medical to Commercialize Eyonis LCS Lung Cancer Screening Software

Reuters
·
Jul 30

Hims & Hers Stock Jumps on Vow to ‘Vigorously’ Defend Against FTC’s ‘Baseless Claims’

TIPRANKS
·
Jul 30